Nikon Corporation Enters into A Business Alliance to Establish A Clinical-Use Master Cell Bank, with Advanced Cell Technology and Engineering Ltd
January 29, 2018 at 04:32 pm
Share
Nikon Corporation has announced a business alliance agreement with Advanced Cell Technology and Engineering Ltd. in order to establish a clinical-use master cell bank (MCB), to be employed for regenerative medicine products derived from dental pulp cells. With this agreement, Nikon CeLL innovation Co. Ltd. is entrusted with business related to the process development of and manufacturing of clinical-use MCBs derived from dental pulp cells to be utilized for regenerative medicine products. Both companies provide optimum quality controlled MCBs derived from dental pulp cells compliant with GCTP and GMP to research institutes and pharmaceutical companies. Under this agreement, both companies will greatly contribute to the acceleration of practical application of regenerative medicine.
Nikon Corporation specializes in the design, manufacturing and marketing of photographic and optic equipments. Net sales break down by family of products as follows:
- precision industrial equipments (39.1%): scanners, LCD steppers, lithography systems, etc.;
- imaging equipments (33%): especially cameras and camcorders;
- diagnostic instruments, microscopes and retinal imaging devices (13.6%);
- optical components (7.6%);
- other (6.7%): industrial measuring instruments, ophthalmic lenses, binoculars, telescopes, magnifiers, etc.
Net sales break down geographically as follows: Japan (18.2%), China (28.4%), the United States (24%), Europe (13.4%) and other (16%).
NIKON CORPORATION 
